The UCSF-GIVI CFAR Virology Core Laboratory provides laboratory services, consultation and training formultidisciplinary, translational research in order to advance collaborators' research programs in theprevention, treatment and understanding of HIV/AIDS. The laboratory typically supports 50 studies annually,ranging from small investigational pilot studies to large, multi-center clinical trials. Collectively, this work hassignificantly broadened our understanding of HIV disease pathogenesis, transmission and treatment.
The specific aims of the laboratory are to provide:1. Service through development and implementation of molecular diagnostic assays and analysis toolsunder strict adherence to rigorous operational procedures and quality assurance programs.2. Research through scientific leadership and laboratory resources to advance our understanding of HIV-1 transmission and correlates of protection that may lead to novel strategies for prevention. Viral replication in the context of latency and partial ARV drug suppression. The causes and consequences of ARV drug resistance. Host factors that modulate HIV replication and evolution. HIV replication and evolution in tissue compartments with a focus on transmission, antiretroviraldrug resistance and disease progression.3. Education and outreach through Mentoring and training of junior investigators and research scientists focused on translationalresearch in local, national and international settings. Consultation with research collaborators, junior scientists and community members to assist inthe interpretation and comprehension of virologic research findings.By collaborating with an increasingly strong network of multidisciplinary basic and clinical scientists, theVirology Core Laboratory is strategically and operationally poised to leverage CFAR funding to effectivelysupport translational research, and advance our understanding of HIV transmission and diseasepathogenesis, identify new and optimize the use of existing antiviral agents, and to guide vaccine design.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI027763-16
Application #
7278983
Study Section
Special Emphasis Panel (ZAI1-EC-A (J1))
Project Start
2007-07-01
Project End
2012-08-31
Budget Start
2007-07-01
Budget End
2008-08-31
Support Year
16
Fiscal Year
2007
Total Cost
$232,508
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Haas, Andreas D; Zaniewski, Elizabeth; Anderegg, Nanina et al. (2018) Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes. J Int AIDS Soc 21:
Dubé, Karine; Gianella, Sara; Concha-Garcia, Susan et al. (2018) Ethical considerations for HIV cure-related research at the end of life. BMC Med Ethics 19:83
Libby, Ashley Rg; Joy, David A; So, Po-Lin et al. (2018) Spatiotemporal mosaic self-patterning of pluripotent stem cells using CRISPR interference. Elife 7:
Jiang, Guochun; Nguyen, Don; Archin, Nancie M et al. (2018) HIV latency is reversed by ACSS2-driven histone crotonylation. J Clin Invest 128:1190-1198
Jin, Harry; Ogunbajo, Adedotun; Mimiaga, Matthew J et al. (2018) Over the influence: The HIV care continuum among methamphetamine-using men who have sex with men. Drug Alcohol Depend 192:125-128
Manuzak, Jennifer A; Gott, Toni M; Kirkwood, Jay S et al. (2018) Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Individuals. Clin Infect Dis 66:1872-1882
Shiboski, Caroline H; Baer, Alan N; Shiboski, Stephen C et al. (2018) Natural History and Predictors of Progression to Sjögren's Syndrome Among Participants of the Sjögren's International Collaborative Clinical Alliance Registry. Arthritis Care Res (Hoboken) 70:284-294
Hansen, Maike M K; Desai, Ravi V; Simpson, Michael L et al. (2018) Cytoplasmic Amplification of Transcriptional Noise Generates Substantial Cell-to-Cell Variability. Cell Syst 7:384-397.e6
Hogan, Louise E; Vasquez, Joshua; Hobbs, Kristen S et al. (2018) Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30. PLoS Pathog 14:e1006856
Sauceda, John A; Neilands, Torsten B; Johnson, Mallory O et al. (2018) An update on the Barriers to Adherence and a Definition of Self-Report Non-adherence Given Advancements in Antiretroviral Therapy (ART). AIDS Behav 22:939-947

Showing the most recent 10 out of 1541 publications